CEACAM5 and breast cancer: Carcinoembryonic antigen (CEA) and carbohydrate antigens (CA) 125, CA 29, CA27, CA 19-9, CA 15-5 and CA 15-3 were discussed for therapy monitoring in BC patients, as well as in direct comparison with the monitoring value of other blood analytes [88,89].